$81.62
0.000.00%
After Hours: Mar 24, 4:00 PM EDT
Comments
Loading...
Dolby Laboratories Stock Guidance | NYSE:DLB | Benzinga
Dolby Laboratories issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/29/2025 | DLB | Dolby Laboratories | FY | 2025 | $3.99 | $4.14 | $4.06 | $1.33B | $1.39B | $1.36B | Get Alert |
| 01/29/2025 | DLB | Dolby Laboratories | Q2 | 2025 | $1.19 | $1.34 | $1.35 | $355.00M | $385.00M | $387.20M | Get Alert |
| 11/19/2024 | DLB | Dolby Laboratories | FY | 2025 | $3.99 | $4.14 | $3.70 | $1.33B | $1.39B | $1.28B | Get Alert |
| 11/19/2024 | DLB | Dolby Laboratories | Q1 | 2025 | $0.96 | $1.11 | $0.70 | $330.00M | $360.00M | $307.94M | Get Alert |
| 08/07/2024 | DLB | Dolby Laboratories | Q4 | 2024 | $0.61 | $0.76 | $0.85 | $300.00M | $320.00M | $326.60M | Get Alert |
| 08/07/2024 | DLB | Dolby Laboratories | FY | 2024 | $3.60 | $3.75 | $3.72 | $1.27B | $1.29B | $1.29B | Get Alert |
| 05/02/2024 | DLB | Dolby Laboratories | FY | 2024 | $3.60 | $3.75 | $3.69 | $1.30B | $1.30B | $1.30B | Get Alert |
| 05/02/2024 | DLB | Dolby Laboratories | Q3 | 2024 | $0.51 | $0.66 | $0.77 | $270.00M | $300.00M | $313.64M | Get Alert |
| 02/01/2024 | DLB | Dolby Laboratories | Q2 | 2024 | $1.14 | $1.29 | $1.17 | $345.00M | $375.00M | $372.47M | Get Alert |
| 02/01/2024 | DLB | Dolby Laboratories | FY | 2024 | $3.60 | $3.75 | $3.72 | $1.30B | $1.30B | $1.30B | Get Alert |
| 11/16/2023 | DLB | Dolby Laboratories | FY | 2024 | $3.60 | $3.75 | $3.45 | $1.30B | $1.30B | $1.30B | Get Alert |
| 11/16/2023 | DLB | Dolby Laboratories | Q1 | 2024 | $0.80 | $0.95 | $1.08 | $300.00M | $330.00M | $353.67M | Get Alert |
| 08/03/2023 | DLB | Dolby Laboratories | FY | 2023 | $3.30 | $3.50 | $3.52 | $1.28B | $1.31B | $1.31B | Get Alert |
| 08/03/2023 | DLB | Dolby Laboratories | Q4 | 2023 | $0.40 | $0.60 | $0.60 | $275.00M | $305.00M | $299.17M | Get Alert |
| 05/04/2023 | DLB | Dolby Laboratories | FY | 2023 | $3.15 | $3.65 | $3.43 | $1.27B | $1.33B | $1.29B | Get Alert |
| 05/04/2023 | DLB | Dolby Laboratories | Q3 | 2023 | $0.47 | $0.62 | $0.71 | $285.00M | $315.00M | $303.92M | Get Alert |
| 02/02/2023 | DLB | Dolby Laboratories | Q2 | 2023 | $0.90 | $1.05 | $0.93 | $340.00M | $370.00M | $332.11M | Get Alert |
| 11/17/2022 | DLB | Dolby Laboratories | Q1 | 2023 | $0.76 | $0.91 | $1.10 | $300.00M | $330.00M | $364.08M | Get Alert |
| 08/09/2022 | DLB | Dolby Laboratories | FY | 2022 | $3.22 | $3.37 | $3.39 | $1.27B | $1.30B | $1.31B | Get Alert |
| 08/09/2022 | DLB | Dolby Laboratories | Q4 | 2022 | $0.68 | $0.83 | $0.87 | $295.00M | $325.00M | $326.80M | Get Alert |
| 05/05/2022 | DLB | Dolby Laboratories | FY | 2022 | $3.27 | $3.77 | $3.80 | $1.30B | $1.35B | $1.37B | Get Alert |
| 05/05/2022 | DLB | Dolby Laboratories | Q3 | 2022 | $0.54 | $0.69 | $1.02 | $285.00M | $310.00M | $340.25M | Get Alert |
| 02/03/2022 | DLB | Dolby Laboratories | Q2 | 2022 | $0.72 | $0.87 | $0.98 | $315.00M | $345.00M | $355.84M | Get Alert |
| 02/03/2022 | DLB | Dolby Laboratories | FY | 2022 | $3.52 | $4.02 | $3.78 | $1.34B | $1.40B | $1.38B | Get Alert |
| 11/16/2021 | DLB | Dolby Laboratories | Q1 | 2022 | $0.98 | $1.13 | $1.31 | $345.00M | $375.00M | $389.77M | Get Alert |
| 11/16/2021 | DLB | Dolby Laboratories | FY | 2022 | $3.52 | $4.02 | $3.94 | $1.34B | $1.40B | $1.37B | Get Alert |
| 07/29/2021 | DLB | Dolby Laboratories | FY | 2021 | $3.57 | $3.72 | $3.51 | $1.28B | $1.31B | $1.29B | Get Alert |
| 07/29/2021 | DLB | Dolby Laboratories | Q4 | 2021 | $0.47 | $0.62 | $0.66 | $280.00M | $310.00M | $304.83M | Get Alert |
| 05/04/2021 | DLB | Dolby Laboratories | Q3 | 2021 | $0.37 | $0.52 | $0.63 | $260.00M | $290.00M | $278.80M | Get Alert |
| 01/28/2021 | DLB | Dolby Laboratories | Q2 | 2021 | $0.57 | $0.72 | $0.62 | $280.00M | $310.00M | $290.10M | Get Alert |
| 11/12/2020 | DLB | Dolby Laboratories | Q2 | 2021 | — | — | — | $270.00M | $300.00M | — | Get Alert |
| 11/12/2020 | DLB | Dolby Laboratories | Q1 | 2021 | $0.97 | $1.12 | $0.56 | $330.00M | $360.00M | $277.94M | Get Alert |
| 08/03/2020 | DLB | Dolby Laboratories | Q4 | 2020 | $0.05 | $0.20 | — | — | — | — | Get Alert |
| 08/03/2020 | DLB | Dolby Laboratories | FY | 2020 | $2.04 | $2.19 | — | — | — | — | Get Alert |
FAQ
What is the most recent guidance for Dolby Laboratories (DLB)?
The most recent guidance for Dolby Laboratories (DLB) was reported on January 29, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $3.99 to $4.14, compared to the estimated EPS of $4.06. Additionally, Dolby Laboratories forecasted revenue between $1.33B and $1.39B for the quarter.
Browse guidance and forecast on all stocks.